Nxera Realigns Strategic Priorities to Advance Next-Generation GPCR Medicines and AI-Enabled Discovery

Nxera Pharma Co., Ltd. announced a focused restructuring designed to concentrate investment and resources on efficient platforms, programs and products w...

November 18, 2025 | Tuesday | News
Scotland Strengthens Position as Global Brain Health Innovator With New Alzheimer’s Research Centre in Aberdeen

Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s research ONE BioHub provides Scott...

November 18, 2025 | Tuesday | News
New England Biolabs Launches Integrated Indexing Primer Module for Streamlined Influenza A Sequencing on Oxford Nanopore Technologies Platforms

Streamlined, high-throughput sequencing of Influenza A virus with integrated indexing for Oxford Nanopore Technologies® platforms New England Biolab...

November 14, 2025 | Friday | News
Pixelgen Technologies and Carolina Molecular Partner to Bring 3D Protein Interactomics to U.S. Researchers

Carolina Molecular Inc., a leading molecular testing services laboratory, and Pixelgen Technologies AB announced  a partnership to expand access to ...

November 13, 2025 | Thursday | News
Atomic Launches to Bridge the Gap Between Breakthrough MedTech Innovation and Venture-Ready Business

-Atomic launches today as a first-of-its-kind service offering for MedTech startups built to bridge the gap between breakthrough concepts and investor-re...

November 13, 2025 | Thursday | News
Basel, Switzerland Emerges as a Global Haven for Life Sciences Talent

Continued uncertainty in the US has many of the world's top scientists considering the Basel area.  Between the government shutdown, crippling inte...

November 12, 2025 | Wednesday | News
Dupixent Delivers First Positive Phase 3 Results in Allergic Fungal Rhinosinusitis

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal cong...

November 10, 2025 | Monday | News
Alvotech and Advanz Pharma Receive UK Marketing Authorisations for Gobivaz®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

November 07, 2025 | Friday | News
Santhera Closes USD 13 Million Royalty Monetization Agreement to Support AGAMREE® Global Launches

 Santhera Pharmaceuticals (SIX: SANN) announces the closing of a USD 13 million royalty monetization agreement, first announced in September 2025, t...

November 06, 2025 | Thursday | News
Enara Bio Expands EDAPT Platform to Include Dark Cell Surface Proteins

  Enara’s discovery of DARKFOX delivers on the vision of translating the dark genome into a new class of clinically actionable Dark Antigens ...

November 05, 2025 | Wednesday | News
Sartorius And Aber Instruments Extend BioPAT® Viamass Integration To Ambr® 250 Advancing Real-Time Biomass Monitoring Across Scales

BioPAT® Viamass provides high resolution real-time viable capacitance-based biomass measurement directly in the cell culture, enabling direct inlin...

November 04, 2025 | Tuesday | News
Eli Lilly to Invest $3 Billion in New European Manufacturing Facility at Leiden Bio Science Park, Netherlands

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain Eli Lilly and Company ...

November 04, 2025 | Tuesday | News
Virax Biolabs Completes Full UK Recruitment for ViraxImmune™ Clinical Study on Long COVID and Related Syndromes

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses t...

November 04, 2025 | Tuesday | News
Bio Usawa Biotechnology Expands to Europe With Launch of Frankfurt-Based Subsidiary

Bio Usawa Biotechnology Ltd (Rwanda) proudly announces the establishment of its new European subsidiary, Bio Usawa Biotech Europe GmbH, headquartered in ...

November 03, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close